Co-Diagnostics, Inc. CORRESP, filed Nov 2, 2020: filename1.htm

November 2, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | Co-Diagnostics, Inc. (the “Company”) | |
| Registration Statement on Form S-3 | ||
| File No. 333-249651 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the Company’s above-referenced Registration Statement be accelerated so that the same will become effective at 2:00 P.M. (EST) on November 5, 2020, or as soon thereafter as is practicable.
| Very truly yours, | ||
| CO-DIAGNOSTICS, INC. | ||
| By: | /s/ Dwight H. Egan | |
| Name: | Dwight H. Egan | |
| Title: | President, Chief Executive Officer and Chairman of the Board of Directors | |
